Y. Hamada

G790del mutation in DSC2 alone is insufficient to develop the pathogenesis of ARVC in a mouse model

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2019, Biochemistry and biophysics reports.

Ryanodine receptor-bound calmodulin is essential to protect against catecholaminergic polymorphic ventricular tachycardia.

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2019, JCI insight.

Correction of impaired calmodulin binding to RyR2 as a novel therapy for lethal arrhythmia in the pressure-overloaded heart failure.

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2017, Heart rhythm.

Mutation-linked, excessively tight interaction between the calmodulin binding domain and the C-terminal domain of the cardiac ryanodine receptor as a novel cause of catecholaminergic polymorphic ventricular tachycardia.

M. Yano, Shigeki Kobayashi, Takeshi Yamamoto, 2018, Heart rhythm.

Nuclear translocation of calmodulin in pathological cardiac hypertrophy originates from ryanodine receptor bound calmodulin.

D. Bers, M. Yano, Shigeki Kobayashi, 2018, Journal of molecular and cellular cardiology.

Relation between Oscillometric Measurement of Central Hemodynamics and Left Ventricular Hypertrophy in Hypertensive Patients

M. Yano, Shigeki Kobayashi, M. Obayashi, 2021, Pulse.